Basic Nimotop Information

• INN (International Nonproprietary Name): Nimodipine.
• Brand Names Available In Canada (English): Nimotop; Nymalize; Nimodipina; Other generics (availability depends on importer registration and local distributors).
• ATC Code: C08CA06.
• Forms & Dosages: Soft gelatin capsule 30 mg (blister strips, tubs); Oral liquid 30 mg/10 mL and 60 mg/10 mL (bottles with dosing syringe).
• Manufacturers In Canada (English): Bayer AG (original brand Nimotop); Arbor Pharmaceuticals (Nymalize in the US); local and regional generic suppliers where registered.
• Registration Status In Canada (English): Not specified in the provided data; verify Health Canada Drug Product Database for DIN and registration before listing.
• OTC / Rx Classification: Prescription only (Rx) in all surveyed jurisdictions.

Availability And Price Landscape

Major National Pharmacy Chains

Worried your local drugstore won't have nimodipine when you need it?

Hospital pharmacies and acute-care suppliers are the primary stock points for nimodipine in Canada.

Large chains such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu will dispense nimodipine by prescription but may need to special-order stock.

Expect longer lead times for branded Nimotop compared with generic nimodipine products.

Community pharmacists often coordinate with hospital discharge planners to secure a 21‑day outpatient supply.

Specialized compounding suppliers and clinic-affiliated online pharmacies can supply oral solution formulations suitable for NG-tube use.

Prescription verification and provincial dispensing rules apply for all retail and online fills.

Patients sometimes encounter delays on weekends or holidays when suppliers are closed.

Online Pharmacy Trends In Canada

Can an online Canadian pharmacy ship nimodipine to my door?

Online Canadian pharmacies verify prescriptions and usually ship only within Canada, following provincial dispensing rules.

Some online suppliers can provide nimodipine oral solution, but shipments may require additional documentation for import or special access if the product lacks a Canadian DIN.

Provincial restrictions vary; community pharmacists must follow provincial college guidance on dispensing and special authorizations.

Cross-border purchasing from the United States or other countries happens, but consumers should confirm Health Canada approval or acceptable import pathways for safety.

Price Ranges By Package Size

How much will nimodipine cost, and does it vary by province?

Price signals differ by formulation: 30 mg soft-gel capsules (typical Nimotop packs overseas) will often be higher when imported or special-ordered.

Oral solution formulations commonly cost more per milligram than capsule forms due to manufacturing and bottle packaging.

Provincial drug plans (Ontario Drug Benefit, BC PharmaCare, RAMQ) may cover inpatient post-SAH care; outpatient coverage depends on plan rules and exceptional-access programs.

Expect price bands rather than fixed national pricing, with rural/remote delivery adding shipping costs and potential delays.

Steps to source: confirm prescription, check provincial coverage, contact local chain for special-order, or query an accredited online pharmacy for solution availability.

Canadian Patient Insights And Satisfaction Levels

Forum And Review Platforms

What do Canadians say about nimodipine on public forums?

Conversations appear on Reddit Canada subreddits such as r/Medicine and r/neurology, on HealthBoards, and in provincial stroke survivor groups.

Patients and caregivers describe nimodipine mainly in acute-care and post‑SAH recovery contexts.

Most reports note hospital initiation of therapy with seamless supply while inpatient.

Outpatient continuation often prompts questions about sourcing and special-order timelines across community pharmacies.

Reported Benefits And Challenges From Canadian Patients

Did nimodipine help? Many patients report clear benefit.

Common themes are gratitude for nimodipine's role in preventing delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage.

Caregivers express frustration when liquid formulations are needed for NG-tube administration and are hard to source quickly.

Anxiety about hypotension and the need for blood-pressure monitoring is frequently mentioned.

Satisfaction with clinical benefit is generally high, while logistical issues and side-effect management lower overall experience scores.

Practical advice from forums: verify Health Canada approval/DIN, work with hospital discharge planners, and avoid any intravenous administration attempts.

Product Overview And Brand Variants

INN And Brand Names Used In Canada

Which brand should you expect to see referenced in prescriptions?

The INN is nimodipine and is the name clinicians will use on prescriptions.

Internationally recognised brand names include Nimotop (Bayer) as 30 mg soft gelatin capsules and Nymalize (Arbor) as an oral solution.

Local generics labelled nimodipina or nimodipine appear in some countries but Canadian availability depends on registrations and imports.

Legal Classification Under Health Canada

Is nimodipine prescription-only in Canada?

Yes, nimodipine is prescription-only (Rx) across surveyed jurisdictions and Canadian practice follows prescription-only dispensing.

Before listing a product, confirm Health Canada licensing and DIN presence for the specific presentation.

Product pages should list registered presentations such as capsules and oral liquid with strength and manufacturer details when available.

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

What is nimodipine prescribed for in Canada?

Nimodipine is used primarily to prevent and treat neurological deficits after aneurysmal subarachnoid haemorrhage (SAH).

Check the DIN-linked product monograph for Canadian-specific approval language before relying on a product listing.

Internationally, the standard adult regimen is 60 mg every 4 hours for 21 days, started within 96 hours of SAH.

Hospital neurosurgical and stroke units routinely include nimodipine in SAH protocols with blood-pressure monitoring.

Off-Label Patterns In Canadian Healthcare

Are there off‑label uses to be aware of?

Off‑label use for other cerebrovascular conditions is rare and should be decided case‑by‑case with neurosurgery or stroke specialists.

Pharmacy product pages must emphasise oral administration only and explicitly state IV use is contraindicated.

When patients require NG-tube dosing, pharmacists should provide or source an oral solution and follow the product monograph for administration guidance.

How It Works In The Body

Layman’s Explanation (Canadian Patient-Friendly Tone)

How does nimodipine protect the brain after a bleed?

Nimodipine is a calcium channel blocker that relaxes blood vessels in the brain to reduce the risk of narrowing after a subarachnoid haemorrhage.

By keeping cerebral vessels more open, it lowers the chance of delayed cerebral ischemia and secondary brain injury.

Patients should understand nimodipine can lower blood pressure, so monitoring is important during treatment.

Clinical Detail From Health Canada Resources

What does the pharmacology say for clinicians?

Nimodipine is an L‑type dihydropyridine (ATC C08CA06) with relative cerebral selectivity and a substantial first‑pass hepatic metabolism.

CYP3A4 metabolism affects systemic exposure and interactions with strong CYP3A4 inhibitors can increase hypotension risk.

Hepatic impairment raises bioavailability and may warrant dose adjustments or closer monitoring.

Dosage And Administration

Standard Regimens Per Canadian Guidelines

What dose should patients expect?

The standard adult oral regimen used internationally and in Canadian practice is 60 mg every 4 hours for 21 consecutive days, started within 96 hours of the bleed.

Only oral administration is permitted, including delivery via nasogastric tube using an oral solution.

Capsules should only be opened or manipulated if the manufacturer monograph or local formulary protocol permits.

Adjustments By Patient Type (With Canadian Clinical Notes)

When should dosing be adjusted?

Children have insufficient data and nimodipine is generally not recommended for paediatric use.

Elderly patients use the same dosing but require closer monitoring for hypotension.

In moderate or severe hepatic impairment, consider dose reduction and tight blood-pressure monitoring due to increased bioavailability.

Renal impairment has no specific documented adjustment; monitor clinically.

For missed doses, take as soon as remembered unless the next dose is near; do not double the dose.

Overdose presents with hypotension and bradycardia and requires supportive care and monitoring.

Contraindications And Side Effects

Common (Health Canada-Approved List)

What common side effects should patients expect?

Hypotension presenting as light-headedness or faintness is the most frequent complaint.

Nausea, bradycardia, peripheral oedema and headache are also reported.

Advise patients to check blood pressure before dosing if they feel unwell and to sit or lie down if dizzy.

Rare But Serious (With Canadian Pharmacovigilance Data)

What are the rare but serious risks?

Profound hypotension and bradyarrhythmias are the most serious risks, especially with inappropriate coadministration of strong CYP3A4 inhibitors.

Do not administer nimodipine intravenously; IV use has been associated with severe and fatal cardiovascular events.

Report suspected serious adverse reactions to Health Canada and document blood-pressure trends in hospital settings during the 21‑day course.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

Is there a direct substitute for nimodipine?

There is no direct equivalent approved for prevention of vasospasm after SAH; other L‑type dihydropyridines such as amlodipine or nifedipine treat systemic hypertension but lack SAH-specific approval.

For example, amlodipine and nifedipine are available in Canada for blood-pressure control but are not substitutes for nimodipine in post‑SAH care.

Pros And Cons List

How do clinicians weigh choices?

Pros for nimodipine: evidence-backed reduction in delayed ischemic deficits after aneurysmal SAH.

Cons: hypotension risk, need for prescription, potential sourcing difficulty for oral solution, and interactions via CYP3A4.

Alternative agents can manage blood pressure but do not replace nimodipine for cerebral vasospasm prevention.

Current Research And Trends

Major Canadian Or International Studies 2022–2025

What is the research focus recently?

Recent studies (2022–2025) have evaluated nimodipine formulation differences and optimal delivery for patients with NG tubes.

Clinical trials have explored ways to preserve cerebral benefit while reducing hypotension and have compared oral liquid versus capsule strategies.

Canadian centres contribute registry data on SAH outcomes and post-discharge nimodipine adherence.

Ongoing research includes pharmacogenomic factors and CYP3A4 interaction impact on individualised dosing.

Common Patient Questions In Canada

Typical FAQs (Dosing, Side Effects, Sourcing)

Can I get nimodipine at my local Shoppers or Rexall?

Yes, nimodipine is available at major chains by prescription but may require special-ordering and lead times.

Is it safe to buy online or cross‑border?

Only purchase from licensed pharmacies and confirm the product has a Health Canada DIN or a documented import protocol and a valid prescription.

Why can't it be given IV?

IV nimodipine has caused severe hypotension and fatalities; only oral or NG administration is permitted.

What should I do if I feel dizzy after a dose?

Stop activity, sit or lie down, check blood pressure, and contact the prescriber if symptoms are severe or persistent.

How Pharmacists Should Respond (Scripted Counselling Points)

What should a pharmacist say at counselling?

Confirm indication (post‑SAH), state the standard dosing schedule (60 mg every 4 hours for 21 days), and review hypotension signs and interactions with strong CYP3A4 inhibitors.

Advise storage below 25°C, provide dosing syringes for liquid formulations, and ensure discharge planners arrange a 21‑day supply.

Recommend reporting adverse events to Health Canada and assist with provincial exceptional‑access paperwork where needed.

Regulatory Status

Health Canada Approval Process

How do you confirm a nimodipine product is allowed in Canada?

Check the Canadian Drug Product Database and the DIN for any product before listing or dispensing.

Health Canada assesses safety, efficacy and quality; imported or special‑access products may require additional documentation.

Hospital procurement should ensure formulary inclusion and documented clinical protocols for prescribing and monitoring.

DIN Number Relevance

Why is the DIN important for pharmacists?

A DIN ties a product to its approved label and is necessary for reimbursement claims and inventory management in Canada.

Verify the DIN to match the product monograph and to confirm dosage forms and indications before dispensing.

When a product lacks a Canadian DIN, follow provincial special‑access or importation processes and document justification in the chart.

Visual Recommendations

Infographic Ideas For Canadian Context

What visuals help patients and clinicians at a glance?

Create a 21‑day timeline showing dosing times (60 mg every 4 hours), BP/HR monitoring checkpoints, and emergency signs that prompt immediate contact.

Include a procurement flow from hospital supply to community pharmacy to provincial reimbursement steps unique to Canada.

Use clear icons for "oral only / no IV," "NG tube compatible," and "alcohol content warning" for some liquid formulations.

Product Photography & Packaging Notes

What product images help trust and adherence?

Photograph capsule blister/tub, liquid bottle with dosing syringe, and close-ups showing DIN, strength and expiry fields.

Note that international pack sizes may differ from Canadian labels; always show alt text for accessibility.

Buying And Storage Advice

In-Store Vs. Online Canadian Purchase Tips

How should patients approach buying nimodipine?

Always have a valid prescription and call ahead to confirm stock or to arrange a special order at local chains.

Online Canadian pharmacies must verify prescriptions and typically ship only within Canada, observing provincial rules.

Cross‑border sourcing is common but carries risks; confirm product formulation and obtain prescriber consent before importing.

In our online pharmacy, nimotop is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Proper Storage With Canadian Climate Considerations

How should nimodipine be stored through Canadian seasons?

Store below 25°C and protect from light; during hot summers avoid leaving bottles or blister packs in cars.

During winter, prevent freezing in transit by using insulated packaging for remote deliveries.

Keep liquids upright and tightly closed and ensure dosing syringe is included for oral solutions.

Dispose of unused medication through pharmacy or municipal hazardous‑waste programs, not in household trash.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

What practical instructions should clinicians give patients and caregivers?

Confirm pre-existing hypotension and interacting drugs before starting nimodipine and instruct patients to monitor BP and HR during outpatient therapy.

Explain the dosing regimen clearly: 60 mg every 4 hours for 21 days, started within 96 hours of SAH.

For NG‑tube patients, use the oral solution or follow the product monograph for permitted capsule manipulation.

Discharge Checklist For Caregivers

What must be arranged before leaving hospital?

Arrange a 21‑day supply with a community pharmacy and confirm liquid formulation availability if NG tube administration is expected.

Counsel patient/caregiver on hypotension signs, provide a clear prescription and emergency contact, and submit provincial exceptional‑access forms if needed.

Document handover between neurosurgery, hospital pharmacy and community pharmacist for continuity of care.

Delivery Across Canada (English)